The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((3S,4S,6S)-4-((S)-1-(benzyloxy)-3-(1H-indol-3-yl)-1-oxopropan-2-ylcarbamoyloxy)-1-oxaspiro[2.5]octan-6-yl)propan-2-yl hex-5-ynoate ID: ALA4224885
PubChem CID: 101771835
Max Phase: Preclinical
Molecular Formula: C35H40N2O7
Molecular Weight: 600.71
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C#CCCCC(=O)OC(C)(C)[C@H]1CC[C@]2(CO2)[C@@H](OC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)OCc2ccccc2)C1
Standard InChI: InChI=1S/C35H40N2O7/c1-4-5-7-16-31(38)44-34(2,3)26-17-18-35(23-42-35)30(20-26)43-33(40)37-29(32(39)41-22-24-12-8-6-9-13-24)19-25-21-36-28-15-11-10-14-27(25)28/h1,6,8-15,21,26,29-30,36H,5,7,16-20,22-23H2,2-3H3,(H,37,40)/t26-,29-,30-,35-/m0/s1
Standard InChI Key: OUZLIMFGHKWCDE-ODSVIUALSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
6.8040 -3.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3974 -3.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9863 -3.8599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9489 -1.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5381 -1.9168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3636 -1.9120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1152 -1.9168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1152 -2.7423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8283 -3.1490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5414 -2.7423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8283 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2571 -3.1527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6882 -2.7445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9732 -3.1562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2571 -2.7465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9744 -3.9818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5421 -3.1582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8260 -2.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1111 -3.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3972 -3.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2575 -3.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9733 -4.3928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5422 -4.3935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9737 -5.2185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6894 -5.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6898 -6.4544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4048 -5.2178 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1164 -5.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8317 -5.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5454 -5.6290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2604 -5.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2604 -4.3921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5396 -3.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8277 -4.3946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2583 -5.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2588 -6.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6751 -7.7288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9326 -6.9434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8495 -7.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5969 -6.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7920 -6.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2427 -7.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5000 -8.1701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3044 -8.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 1 0
5 6 1 1
4 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 5 1 0
5 11 1 0
10 12 1 1
8 2 1 1
2 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 3 0
12 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
24 35 1 6
35 36 1 0
36 40 1 0
39 37 1 0
37 38 1 0
38 36 2 0
39 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 600.71Molecular Weight (Monoisotopic): 600.2836AlogP: 5.61#Rotatable Bonds: 12Polar Surface Area: 119.25Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.35CX Basic pKa: ┄CX LogP: 5.90CX LogD: 5.90Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.09Np Likeness Score: 0.51
References 1. Wang P, Jiang L, Cao Y, Zhang X, Chen B, Zhang S, Huang K, Ye D, Zhou L.. (2018) Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation., 26 (8): [PMID:29530347 ] [10.1016/j.bmc.2018.02.044 ] 2. Jiang K,Gao B,Yu J,Jiang L,Niu A,Jia Y,Meng T,Zhou L,Wang J. (2021) Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors., 36 [PMID:33513389 ] [10.1016/j.bmcl.2021.127820 ]